Medical professionals in the Philippines are raising concerns over the growing impact of diabetes as the leading contributor to chronic kidney disease (CKD), a condition that continues to place significant strain on both patients and the national healthcare system.
Chronic kidney disease is characterised by the gradual and irreversible decline of kidney function, often progressing silently until advanced stages. According to the World Health Organization (WHO), CKD is a major global health issue, frequently associated with non-communicable diseases such as diabetes and hypertension. In the Philippines, clinicians report that diabetes remains the primary driver of kidney failure, largely due to delayed diagnosis and inadequate disease control.
Experts highlight that many individuals may be unaware they are living with diabetes, allowing complications to develop undetected. Scientific literature, including studies published in The Lancet Diabetes & Endocrinology, indicates that prolonged elevated blood glucose levels can damage blood vessels in the kidneys, impairing their ability to filter waste effectively.
Hypertension, genetic kidney disorders, urinary tract conditions and kidney stones are also recognised as contributing factors. However, poorly managed diabetes significantly accelerates the deterioration of renal function. Research published in The BMJ suggests that individuals with uncontrolled diabetes experience a markedly faster decline in kidney performance compared to those with stable metabolic control.
Age is another important determinant. Kidney function naturally decreases over time, but this decline can be exacerbated by chronic conditions. Clinical observations in the Philippines show that most CKD patients fall within middle to older age groups, although cases have also been identified in much younger individuals, underscoring the unpredictable nature of the disease.
Early detection remains a critical challenge. Routine screening methods, such as urinalysis to identify protein in the urine, are widely recommended by nephrology guidelines as an initial indicator of kidney impairment. According to the Clinical Journal of the American Society of Nephrology, early identification allows for timely interventions that can slow disease progression and reduce the need for dialysis.
In recent years, healthcare policy in the Philippines has expanded financial support for dialysis treatment through national insurance programmes. This has improved access to life-sustaining therapy for patients with end-stage kidney disease, contributing to a noticeable increase in the number of individuals undergoing dialysis. While this development enhances quality of life for many, it also reflects the growing prevalence of advanced CKD.
Beyond treatment, organ donation remains a critical yet underutilised component of kidney disease management in the Philippines. Transplantation offers a more sustainable long-term solution compared to dialysis; however, low rates of consent for deceased organ donation continue to limit its availability. Studies in The Lancet highlight that public awareness and cultural perceptions play a significant role in organ donation rates worldwide.
Healthcare professionals in the Philippines are therefore calling for a stronger emphasis on prevention, education and early intervention. Addressing modifiable risk factors—such as blood sugar control, blood pressure management and regular health screening—could significantly reduce the burden of CKD.
The situation illustrates a broader global trend in which non-communicable diseases are increasingly driving complex and costly health conditions. In the Philippines, tackling diabetes effectively may prove to be one of the most important strategies in curbing the rise of chronic kidney disease and improving long-term public health outcomes.